SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-20-028105
Filing Date
2020-12-11
Accepted
2020-12-11 08:22:58
Documents
12
Period of Report
2020-12-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K/A nt10017732x6_8ka.htm   iXBRL 8-K/A 47639
  Complete submission text file 0001140361-20-028105.txt   195786

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rckt-20201206.xsd EX-101.SCH 4207
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20201206_lab.xml EX-101.LAB 23468
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20201206_pre.xml EX-101.PRE 16738
5 EXTRACTED XBRL INSTANCE DOCUMENT nt10017732x6_8ka_htm.xml XML 4383
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36829 | Film No.: 201382297
SIC: 2834 Pharmaceutical Preparations